Mineralys Therapeutics Stock Discussion

$Mineralys Therapeutics (MLYS.US)$
Breakthrough Hypertension Treatment Shows 15.4 mmHg Blood Pressure Reduction in NEJM-Published Trial

$Mineralys Therapeutics (MLYS.US)$
Breakthrough Hypertension Drug Achieves 15.4 mmHg Blood Pressure Drop in Critical Phase 2 Trial

$Mineralys Therapeutics (MLYS.US)$
Breakthrough Hypertension Drug Achieves 15.4 mmHg Blood Pressure Drop in Critical Phase 2 Trial

$Mineralys Therapeutics (MLYS.US)$ need 5mil more volume and this would really get moving ...

$Mineralys Therapeutics (MLYS.US)$
03/10/2025 - 04:00 AM
– Launch-HTN met its primary endpoint with lorundrostat 50 mg dose achieving a 16.9 mmHg reduction in systolic blood pressure, and a 9.1 mmHg placebo-adjusted reduction (p-value < 0.0001) assessed by automated office blood pressure at week 6 –
– Launch-HTN met a predefined endpoint with lorundrostat 50 mg dose achieving a 19.0 mmHg reduction in systolic blood pressure, and an 11.7 mmHg placebo-adjusted reduction (p-value < 0.0001) asse...

$Mineralys Therapeutics (MLYS.US)$No insider trading information for phase 2 is a little tricky to
I find this to be very shady
I'm staying away from this one good luck people

$Mineralys Therapeutics (MLYS.US)$
Why am I unable to find any information about this phase 2 trial for this drug it just does it say unless I'm missing it I don't see where they gave the report for phase 2

$Mineralys Therapeutics (MLYS.US)$
Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension

$Mineralys Therapeutics (MLYS.US)$ halt pending news